183 related articles for article (PubMed ID: 37226019)
1. The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study.
Bryl K; Chimonas S; Li X; Li SQ; Mao JJ
Breast Cancer Res Treat; 2023 Jul; 200(2):257-264. PubMed ID: 37226019
[TBL] [Abstract][Full Text] [Related]
2. Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.
Dorfman CS; Arthur SS; Kimmick GG; Westbrook KW; Marcom PK; Corbett C; Edmond SN; Shelby RA
Menopause; 2019 Aug; 26(8):823-832. PubMed ID: 30994574
[TBL] [Abstract][Full Text] [Related]
3. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
Mension E; Alonso I; Anglès-Acedo S; Ros C; Otero J; Villarino Á; Farré R; Saco A; Vega N; Castrejón N; Ordi J; Rakislova N; Tortajada M; Matas I; Gómez S; Ribera L; Castelo-Branco C
JAMA Netw Open; 2023 Feb; 6(2):e2255697. PubMed ID: 36763359
[TBL] [Abstract][Full Text] [Related]
4. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.
Advani P; Brewster AM; Baum GP; Schover LR
J Cancer Surviv; 2017 Aug; 11(4):477-485. PubMed ID: 28229275
[TBL] [Abstract][Full Text] [Related]
5. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
Buchholz S; Mögele M; Lintermans A; Bellen G; Prasauskas V; Ortmann O; Grob P; Neven P; Donders G
Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
[TBL] [Abstract][Full Text] [Related]
6. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.
Bromley SE; Matthews A; Smeeth L; Stanway S; Bhaskaran K
J Cancer Surviv; 2019 Aug; 13(4):632-640. PubMed ID: 31321612
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors.
Desai K; Mao JJ; Su I; Demichele A; Li Q; Xie SX; Gehrman PR
Support Care Cancer; 2013 Jan; 21(1):43-51. PubMed ID: 22584732
[TBL] [Abstract][Full Text] [Related]
8. Sexual function after breast cancer.
Panjari M; Bell RJ; Davis SR
J Sex Med; 2011 Jan; 8(1):294-302. PubMed ID: 21199377
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors.
Kallak TK; Baumgart J; Göransson E; Nilsson K; Poromaa IS; Stavreus-Evers A
Menopause; 2014 Apr; 21(4):383-90. PubMed ID: 24080848
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D and cancer-related fatigue: associations and effects on depression, anxiety, functional capacity and health-related quality of Life in breast cancer survivors during adjuvant endocrine therapy.
Custódio IDD; Nunes FSM; Lima MTM; de Carvalho KP; Alves DS; Chiaretto JF; Canto PPL; Paiva CE; de Paiva Maia YC
BMC Cancer; 2022 Aug; 22(1):860. PubMed ID: 35933326
[TBL] [Abstract][Full Text] [Related]
11. A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
Sánchez-Rovira P; Hirschberg AL; Gil-Gil M; Bermejo-De Las Heras B; Nieto-Magro C
Oncologist; 2020 Dec; 25(12):e1846-1854. PubMed ID: 32459035
[TBL] [Abstract][Full Text] [Related]
12. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
[TBL] [Abstract][Full Text] [Related]
13. Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey.
Smedsland SK; Vandraas KF; Bøhn SK; Dahl AA; Kiserud CE; Brekke M; Falk RS; Reinertsen KV
Breast Cancer Res Treat; 2022 May; 193(1):139-149. PubMed ID: 35226237
[TBL] [Abstract][Full Text] [Related]
14. Sexual Dysfunction in Survivorship; the Impact of Menopause and Endocrine Therapy.
Kuehn R; Casaubon J; Raker C; Edmonson D; Stuckey A; Gass J
Ann Surg Oncol; 2019 Oct; 26(10):3159-3165. PubMed ID: 31342358
[TBL] [Abstract][Full Text] [Related]
15. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
Melisko ME; Goldman ME; Hwang J; De Luca A; Fang S; Esserman LJ; Chien AJ; Park JW; Rugo HS
JAMA Oncol; 2017 Mar; 3(3):313-319. PubMed ID: 27832260
[TBL] [Abstract][Full Text] [Related]
16. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.
Schover LR; Baum GP; Fuson LA; Brewster A; Melhem-Bertrandt A
J Sex Med; 2014 Dec; 11(12):3102-11. PubMed ID: 25141792
[TBL] [Abstract][Full Text] [Related]
17. Comparing exercise responses to aerobic plus resistance training between postmenopausal breast cancer survivors undergoing aromatase inhibitor therapy and healthy women.
de Paulo TRS; Winters-Stone KM; Viezel J; Rossi FE; Aro BL; Trindade ACAC; Codogno JS; Freitas Junior IF
Disabil Rehabil; 2019 Sep; 41(18):2175-2182. PubMed ID: 29644889
[No Abstract] [Full Text] [Related]
18. The impact of bone mineral density screening on incident fractures and healthcare resource utilization among postmenopausal breast cancer survivors treated with aromatase inhibitors.
Bailey S; Mhango G; Lin JJ
Osteoporos Int; 2022 Sep; 33(9):1989-1997. PubMed ID: 35697870
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors.
Romero SAD; Su HI; Satagopan J; Li QS; Seluzicki CM; Dries A; DeMichele AM; Mao JJ
Breast; 2020 Feb; 49():48-54. PubMed ID: 31678641
[TBL] [Abstract][Full Text] [Related]
20. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Carter J; Baser RE; Goldfrank DJ; Seidel B; Milli L; Stabile C; Canty J; Saban S; Goldfarb S; Dickler MN; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
Support Care Cancer; 2021 Jan; 29(1):311-322. PubMed ID: 32358778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]